White papers

Ensuring quality with flexibility- Olink® Flex validation & verification

This white paper transparently presents some of the results from our verification and validation tests carried out during the development of Olink Flex.

It’s all relative – 4 reasons why biomarker discovery commonly uses relative quantification

In this white paper, four reasons why relative quantification remains the prevalent method for biomarker discovery are provided.

Pre-analytical variation in protein biomarker research

This white paper highlights some of the factors to consider when collecting, storing, and handling human blood samples for use in protein biomarker studies.

The Olink PEA platform

This white paper describes the Proximity Extension Assay (PEA) technology that underlies Olink’s panels for protein biomarker discovery, development, and implementation.

Measuring protein biomarkers with Olink

This white paper compares data from Olink studies with single- and multiplex technologies, with added tips on how to work with protein data from multiple platforms.

Development and validation of customized PEA panels

This white paper describes a proof-of-principle study where a customized 19-plex panel was developed and optimized for future clinical utility.

Data normalization and standardization

This white paper describes how Olink data is processed and normalized to generate our Normalized Protein eXpression (NPX) values from an Olink study.

Strategies for design of protein biomarker studies

This white paper describes important aspects of study design to consider when planning your future research.